Incidental finding of cornea verticillata or lamellar inclusions in kidney biopsy: measurement of lyso-Gb3 in plasma defines between Fabry disease and drug-induced phospholipidosis-Reference-Cited by-同舟云学术

Incidental finding of cornea verticillata or lamellar inclusions in kidney biopsy: measurement of lyso-Gb3 in plasma defines between Fabry disease and drug-induced phospholipidosis

Published:2021-01 Issue:1 Volume:1867 Page:165985
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Politei J.,Frabasil J.,Durand C.,Di Pietrantonio S.,Fernandez A.,Albertón V.,Velasquez Rivas D.,Barriales-Villa R.,Larrañaga-Moreira J.,Schenone A.B.

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference22 articles.

1. Fabry disease revisited: management and treatment recommendations for adult patients;Ortiz;Mol. Genet. Metab.,2018

2. Plasma lyso-Gb3: a useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes;Nowak;Mol. Genet. Metab.,2017

3. Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine;Lüllmann;CRC Crit. Rev. Toxicol.,1975

4. Emerging mechanisms of drug-induced phospholipidosis;Breiden;Biol. Chem.,2019

5. Lysosomal glycosphingolipid storage in chloroquine-induced alpha-galactosidase-deficient human endothelial cells with transformation by simian virus 40: in vitro model of Fabry disease;Inagaki;Acta Neuropathol.,1993

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxychloroquine-Induced Renal Phospholipidosis: Case Report and Review of Differential Diagnoses;Case Reports in Nephrology and Dialysis;2024-02-16

2. Anderson–Fabry Disease: Red Flags for Early Diagnosis of Cardiac Involvement;Diagnostics;2024-01-18

3. Ophthalmologic implications to consider when using hydroxychloroquine to treat COVID-19 and induced arthritis;World Journal of Experimental Medicine;2023-09-20

4. 2023 ESC Guidelines for the management of cardiomyopathies;European Heart Journal;2023-08-25

5. Clinical Diagnosis and Treatment Progress of Fabry Disease;Advances in Clinical Medicine;2023